Joseph T. Curti
Directeur/Membre du Conseil chez Morehouse School of Medicine
Profil
Joseph T.
Curti is a trustee at Morehouse School of Medicine.
He was previously the President & Chief Executive Officer at BELLUS Health, Inc. and Ferring Pharmaceuticals, Inc. He also served as a Director at Interpace Biosciences, Inc. and as President-North American Operations at Searle Research & Development.
Curti holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from St. Joseph's University.
Postes actifs de Joseph T. Curti
| Sociétés | Poste | Début |
|---|---|---|
| Morehouse School of Medicine | Directeur/Membre du Conseil | - |
Anciens postes connus de Joseph T. Curti
| Sociétés | Poste | Fin |
|---|---|---|
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | President | 01/01/1998 |
| Searle Research & Development | Corporate Officer/Principal | - |
| BELLUS HEALTH | President | - |
| INTERPACE BIOSCIENCES, INC. | Directeur/Membre du Conseil | - |
Formation de Joseph T. Curti
| Thomas Jefferson University | Doctorate Degree |
| St. Joseph's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTERPACE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
| Searle Research & Development |